Popular topics to explore
DRREDDY
Dr Reddy’s Laboratories on Wednesday said its consolidated net profit increased nearly 2 percent year-on-year to Rs 1,418 crore during the June quarter. The Hyderabad-based drug firm had reported a net profit of Rs 1,392 crore during the April-June period of the previous fiscal year.
Revenue increased 11.4 percent to Rs 8,545 crore for the period under review as against Rs 7,672.7 crore in the year-ago period, Dr Reddy’s Laboratories said in a regulatory filing.
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew 5 percent to Rs 2,278 crore in the first quarter of June 2025. The same was reported at Rs 2,160 Cr in the same period a year ago. The margin was reported at 26.7 percent against 28.2 percent year-on-year (YoY).#StockInNews#FundamentalViews#Post-ClosingCommentary#EquityResearch
904 likes·74 comments

















